Mölnlycke Health Care is a world-leading provider of single-use surgical and wound care products for customers, healthcare professionals and patients.
We develop and bring to market innovative wound care and surgical products for use in a range of settings – from prevention through acute care to homecare. Our products include:
•Gentle, effective dressings with Safetac® techonogy, such as Mepitel® and Mepilex®, to prevent, protect and heal a wide range of wounds
•Safe, efficient, single-use surgical products, such as Biogel® surgical gloves – to minimize infections and increase efficiency in the operating room and beyond
•Avance® for negative pressure wound therapy.
High quality is important to us – because we put patients and our customers at the heart of everything we do. Our products provide value for money, supported by clinical and health economic evidence. And we strive to find new ways to minimize community and hospital-acquired conditions.
Mölnlycke Health Care employs around 7,500 people and is owned by Investor AB. The company headquarters are in Gothenburg, Sweden and we operate in 90 countries worldwide. We call upon all our staff – wherever they are in the world – to live by our values of passion, learning and integrity.